Targeting breast cancer stem cells by a self-assembled, aptamer-conjugated DNA nanotrain with preloading doxorubicin
Zhiyuan Xu,1 Ronghua Ni,1 Yun Chen1,21School of Pharmacy, Nanjing Medical University, Nanjing 211166, People’s Republic of China; 2State Key Laboratory of Reproductive Medicine, Nanjing 210029, People’s Republic of ChinaCorrespondence: Yun ChenSchool of Pharmacy, Nanjing Medical...
Saved in:
| Main Authors: | Xu Z, Ni R, Chen Y |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2019
|
| Subjects: | |
| Online Access: | https://doaj.org/article/9b7e21103242479c8ff792d889d18abf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design and clinical developments of aptamer-drug conjugates for targeted cancer therapy
by: Do-Hun Kim, et al.
Published: (2021) -
Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
by: Dou XQ, et al.
Published: (2018) -
Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
by: Yao F, et al.
Published: (2020) -
Aptamer-Conjugated Quantum Dot Optical Biosensors: Strategies and Applications
by: Dongmin Kim, et al.
Published: (2021) -
Nucleic Acid-Based Treatments Against COVID-19: Potential Efficacy of Aptamers and siRNAs
by: Javad Khanali, et al.
Published: (2021)